Literature DB >> 26860879

Effectiveness of a Brief Psychosocial Intervention on Quality of Life of Primary Caregivers of Iranian Children With Cancer: A Randomized Controlled Trial.

Atefeh Safarabadi-Farahani1, Masoomeh Maarefvand2, Akbar Biglarian3, Jagdish Khubchandani4.   

Abstract

UNLABELLED: Cancer in children has a great impact on primary caregiver quality of life (QOL).
OBJECTIVE: This study examined the effectiveness of a brief psychosocial intervention (BPI) on QOL of Primary Caregivers of Children with Cancer (PCCCs).
METHODS: Sixty-five PCCCs participated in a randomized controlled trial in Mahak Hospital and Rehabilitation Complex in Tehran, Iran. A 5-week long BPI (which comprised of counseling sessions and telephone follow-up) was delivered to the intervention group in addition to usual service, while the control group was provided with usual service. Data were collected using the Caregiver Quality of Life Index-Cancer-Persian version (CQOLC-P) prior to intervention, post-intervention, and at follow-up (i.e. 30days after the intervention). Repeated measures analysis of variance analysis (ANOVA) was used to evaluate outcomes.
RESULTS: Majority of the participants were mothers (95%), between ages of 24-47 years (95%) with children between ages of 2-12 years. Most child cancer diagnoses were for brain tumors (n=31) and blood cancers (n=17). Significant improvement was found within the intervention group on QOL (p<0.001) including improvements on subscale measures of mental/emotional burden (p<0.001), disruption (p<0.001), and positive adaptation (p<0.001), compared with the control group over time. There was no difference between the intervention and control groups on the financial subscale measure after intervention (p>0.05).
CONCLUSION: BPI was an effective strategy to improve the quality of life of PCCCs. Similar interventions can be planned by practitioners to reduce the burden of childhood cancer on PCCCs.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; Children; Intervention; Primary caregiver; Quality of life

Mesh:

Year:  2016        PMID: 26860879     DOI: 10.1016/j.pedn.2016.01.002

Source DB:  PubMed          Journal:  J Pediatr Nurs        ISSN: 0882-5963            Impact factor:   2.145


  5 in total

1.  Interventions to help support caregivers of people with a brain or spinal cord tumour.

Authors:  Florien W Boele; Alasdair G Rooney; Helen Bulbeck; Paula Sherwood
Journal:  Cochrane Database Syst Rev       Date:  2019-07-02

2.  Psychosocial Intervention Programs for Parents of Children with Cancer: A Systematic Review and Critical Comparison of Programs' Models and Development.

Authors:  David Ogez; Katherine Péloquin; Laurence Bertout; Claude-Julie Bourque; Daniel Curnier; Simon Drouin; Caroline Laverdière; Valérie Marcil; Rebeca Ribeiro; Melissa Callaci; Emélie Rondeau; Daniel Sinnett; Serge Sultan
Journal:  J Clin Psychol Med Settings       Date:  2019-12

3.  Definition and improvement of the concept and tools of a psychosocial intervention program for parents in pediatric oncology: a mixed-methods feasibility study conducted with parents and healthcare professionals.

Authors:  David Ogez; Claude-Julie Bourque; Katherine Péloquin; Rebeca Ribeiro; Laurence Bertout; Daniel Curnier; Simon Drouin; Caroline Laverdière; Valérie Marcil; Émélie Rondeau; Daniel Sinnett; Serge Sultan
Journal:  Pilot Feasibility Stud       Date:  2019-02-06

4.  Informal caregiver burden and influencing factors in gynaecological oncology patients hospitalized for chemotherapy: a cross-sectional study.

Authors:  Yan Zuo; Bi-Ru Luo; Wen-Tao Peng; Xin-Ru Liu; Ya-Lin He; Jian-Jun Zhang
Journal:  J Int Med Res       Date:  2020-11       Impact factor: 1.671

5.  Association of Visual Acuity with Eye-Related Quality of Life and Functional Vision Across Childhood Eye Conditions.

Authors:  David A Leske; Sarah R Hatt; Suzanne M Wernimont; Yolanda S Castañeda; Christina S Cheng-Patel; Laura Liebermann; Eileen E Birch; Jonathan M Holmes
Journal:  Am J Ophthalmol       Date:  2020-10-28       Impact factor: 5.258

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.